MTIM
BMY icon

Marathon Trading Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Marathon Trading Investment Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$97K Buy
+1,600
New +$93.3K ﹤0.01% 219
2021
Q1 		– Sell
-12,300
Closed -$763K – 404
2020
Q4 		$763K Buy
+12,300
New +$756K 0.04% 179
2019
Q2 		– Sell
-15,000
Closed -$716K – 226
2019
Q1 		$716K Buy
+15,000
New +$747K 0.08% 153
2015
Q1 		– Sell
-895,000
Closed -$52.8M – 482
2014
Q4 		$52.8M Buy
+895,000
New +$50.5M 0.76% 25

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Marathon Trading Investment Management's BMY Position: Q1 2026 in Review

Marathon Trading Investment Management opened a new position in Bristol-Myers Squibb (BMY) in Q1 2026: 198 shares worth $12K. The stake represents ﹤0.01% of the portfolio and ranks #258 among its holdings. This is a return to the name: Marathon Trading Investment Management previously reported a position in BMY as recently as Q4 2023.

Marathon Trading Investment Management first reported a position in BMY in Q4 2014 and has held it in 8 quarters since. The position peaked at $17M in Q4 2014. 2,528 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Marathon Trading Investment Management held 198 shares of Bristol-Myers Squibb worth $12K as of Q1 2026.
  • Bristol-Myers Squibb was a new Marathon Trading Investment Management position in Q1 2026.
  • Bristol-Myers Squibb made up ﹤0.01% of Marathon Trading Investment Management's portfolio in Q1 2026, its #258 holding.
  • Marathon Trading Investment Management first reported a position in Bristol-Myers Squibb in Q4 2014 and has held it in 8 quarters since.
  • Marathon Trading Investment Management's Bristol-Myers Squibb position peaked at $17M in Q4 2014.
  • 2,528 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Marathon Trading Investment Management's 13F filing for Q1 2026, filed 14 May 2026.